List of Gonitro drug patents

Gonitro is owned by Pohl Boskamp.

Gonitro contains Nitroglycerin.

Gonitro has a total of 1 drug patent out of which 0 drug patents have expired.

Gonitro was authorised for market use on 08 June, 2016.

Gonitro is available in powder;sublingual dosage forms.

The generics of Gonitro are possible to be released after 11 March, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9101592 POHL BOSKAMP Stabilized granules containing glyceryl trinitrate
Mar, 2032

(9 years from now)

Drugs and Companies using NITROGLYCERIN ingredient

Market Authorisation Date: 08 June, 2016

Treatment: NA

Dosage: POWDER;SUBLINGUAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in